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Examining the basic mechanisms by which lithogenic diet-
induced hepatic protein kinase Cb (PKCb) expression initi-
ates signal transduction pathways to control cholesterol
metabolism reveals novel ileum and liver PKCb regulatory
axes critical for ﬁne-tuning hepatic cholesterol content and
bile lithogenicity.
BACKGROUND & AIMS: Dietary factors are likely an important
determinant of gallstone development, and difﬁculty in adapt-
ing to lithogenic diets may predispose individuals to gallstone
formation. Identiﬁcation of the critical early diet-dependent
metabolic markers of adaptability is urgently needed to pre-
vent gallstone development. We focus on the interaction be-
tween diet and genes, and the resulting potential to inﬂuence
gallstone risk by dietary modiﬁcation.
METHODS: Expression levels of hepatic protein kinase C (PKC)
isoforms were determined in lithogenic diet-fed mice, and the
relationship of hepatic cholesterol content and PKCb expres-
sion and the effect of hepatic PKCb overexpression on intra-
cellular signaling pathways were analyzed.
RESULTS: Lithogenic diet feeding resulted in a striking induc-
tion of hepatic PKCb and PKCd mRNA and protein levels, which
preceded the appearance of biliary cholesterol crystals. Unlike
PKCb deﬁciency, global PKCd deﬁciency did not inﬂuence
lithogenic diet-induced gallstone formation. Interestingly, a
deﬁciency of apolipoprotein E abrogated the diet-induced
hepatic PKCb expression, whereas a deﬁciency of liver X
receptor-a further potentiated the induction, suggesting a
potential link between the degree of hepatic PKCb induction
and the intracellular cholesterol content. Furthermore, our re-
sults suggest that PKCb is a physiologic repressor of ileum basal
ﬁbroblast growth factor 15 (FGF15) expression and activity of
hepatic proto-oncogene serine/threonine-protein kinase Raf-1/
mitogen-activated protein (MAP) kinase kinase/extracellular
signal-regulated kinases 1/2 (Raf-1/MEK/ERK1/2) cascade
proteins, and the complex interactions between these pathways
may determine the degree of hepatic ERK1/2 activation, a
potent suppressor of cholesterol 7a-hydroxylase and sterol
12a-hydroxylase expression. We found that PKCb regulated
Raf-1 activity by modulating the inhibitory Raf-1Ser259
phosphorylation.
CONCLUSIONS: Our results demonstrate a novel interaction
between the hepatic PKCb/Raf-1 regulatory axis and ileum
PKCb/FGF15/ERK axis, which could modulate the bilelithogenecity of dietary lipids. The data presented are consistent
with a two-pronged mechanism by which intestine and liver
PKCb signaling converges on the liver ERK1/2 pathway to con-
trol the hepatic adaptive response to a lithogenic diet. Eluci-
dating the impact and the underlying mechanism(s) of PKCb
action could help us understand how different types of dietary
fat modify the risk of gallstone formation, information that could
help to identify novel targets for therapeutic approaches to
combat this disease. (Cell Mol Gastroenterol Hepatol
2015;1:395–405; http://dx.doi.org/10.1016/j.jcmgh.2015.05.008)
Keywords: Hepatic Cholesterol Metabolism; Lithogenic Diet;
Signal Transduction; Protein Kinase Cb.
holesterol gallstone disease is characterized by theCperturbations of the physical-chemical balance of
cholesterol solubility in bile, resulting in a nonphysiologic
cholesterol saturation level.1 Hypersecretion of nonesteri-
ﬁed cholesterol into bile appears to represent the key mo-
lecular mechanism of gallstone formation in susceptible
mouse models and in humans. The source of cholesterol
destined for biliary secretion has not been identiﬁed, but a
major source is thought to be the preexisting hepatic
cholesterol pool and dietary cholesterol.
Whole body cholesterol homeostasis reﬂects a balance
between endogenous cholesterol synthesis, dietary uptake,
reverse cholesterol transport, and biliary excretion. The
liver plays a critical role in nutrient sensing, the regulation
of cholesterol synthesis, the conversion of cholesterol into
bile acids, the secretion of cholesterol into bile either
directly or as bile salts, the uptake and hydrolysis/meta-
bolism of plasma cholesterol in the form of high-density li-
poprotein or low-density lipoprotein (LDL) particles, the
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cholesterol into the plasma. Liver cholesterol metabolism
relies on an intricate network of cellular regulatory pro-
cesses and dysregulation can lead to several life-threatening
pathologies, such as hypercholesterolemia, cardiovascular
disease, and gallstone disease.2 The rate-limiting enzyme for
the major pathway of hepatic bile acid synthesis is choles-
terol 7a-hydroxylase (Cyp7a1).
The regulation of Cyp7a1 in mice occurs via the nuclear
receptors farnesoid X receptor (FXR) and liver X receptor
(LXR). FXR responds to endogenous bile acid ligands to
induce feedback loops that both repress bile acid synthesis
and enhance the hepatic secretion of bile acids into bile. FXR
may suppress bile acid synthesis via the up-regulation of a
nuclear receptor small heterodimer partner, although
ﬁbroblast growth factor (FGF) 15/19 may also play an
important regulatory role.3 Oxysterols are the endogenous
ligands for LXR, and LXR stimulation in mice increases
expression of Cyp7a1. This increases the rate of bile acid
synthesis and thus increases the systemic elimination of
cholesterol.4 Several previous studies have indicated a role
for protein kinase Cs (PKCs) in modulating the functions of
multiple nuclear receptors in vitro, including FXR, LXRs,
vitamin D receptor, and FGF signaling pathway proteins.5–10
However, few studies have determined whether PKCs can
regulate bile lithogenicity by inducing metabolic adaptations
in the liver and intestine. To date, there is no information
regarding the direct regulation and activation of PKC iso-
forms in the liver by a lithogenic diet. Speciﬁcally, which
particular PKC isoforms are altered in the livers of lithogenic
diet-fed animals and their inﬂuence on gallstone formation
remain unknown.
Our recent study suggests that PKCb might be a pivotal
protein regulating cholesterol homeostasis.11 Interestingly,
deﬁciency of PKCb sensitized mice to the development of
cholesterol gallstone disease and is associated with reduced
expression of Cyp7a1 and Cyp8b1, leading to increased
biliary cholesterol saturation and hydrophobicity indices.
These results suggest that PKCb could be a target for the
study of the pathogenesis of cholesterol gallstones in
response to nutritional changes. However, the exact role and
signaling pathway(s) by which PKCb modulates Cyp7a1 and
Cyp8b1 gene expression remain unknown. To determine
how PKCb deﬁciency triggers the development of gallstone
in response to lithogenic diet intake, we determined litho-
genic diet-PKCb interaction and the impact of PKCb
signaling on pathways modulating hepatic cholesterol ho-
meostasis. Our results identiﬁed a diet-sensitive regulatory
axis involving PKCb, FGF15, and Raf-1 hepatic proto-
oncogene serine/threonine-protein kinase (Raf-1) in which
the loss of PKCb altered FGF15 action by modulating its
expression, and activity of hepatic Raf-1/mitogen-activated
protein (MAP) kinase kinase/extracellular signal regulated
kinase-1/2 (Raf-1/MEK/ERK) cascade. This resulted in ﬁne-
tuning of the hepatic cholesterol content and bile lith-
ogenicity. Thus, hepatic PKCb induction and induced
changes in signaling and gene transcription may constitute a
possible mechanism for the chronic adaptations to litho-
genic diets. This study suggests that the modulation of PKCbactivity in the ileum and/or liver may be an effective
approach to reduce the risk of gallstone formation.
Materials and Methods
Animals and Diets
PKCb/ mice on a C57BL6 background were described
previously elsewhere.11 Generation of PKCd/ mice on a
C57/129 Sv background was described by Miyamoto et al.12
All mice were housed in a temperature-controlled room
(22C) with a 12-hour light/dark cycle, and were main-
tained on a standard rodent diet (7912 rodent chow;
Harland Teklad, Madison, WI). Eight-week-old wild-type
(WT) and PKCb/ mice were fed a modiﬁed-milk fat
lithogenic diet (MMLD; Teklad TD-10014; Harland Teklad)
containing (by weight) 15% anhydrous milk fat, 1%
cholesterol, and 0.5% cholate for the indicated periods. The
PKCd/ and WT littermates were fed MMLD for 2 or 5
weeks. Mice were fed ad libitum with free access to water.
Unless indicated, all experiments were performed on non-
fasted male mice, and the mice were euthanized in the
morning. All procedures and experiments on mice were
approved by institutional animal care and use committee of
the Ohio State University.
Experimental Protocol and Tissues and
Bile Harvest
For gallbladder bile collection, mice were fasted for 4
hours before euthanasia. The gallbladder was ligated, and
the bile was collected through a fundus incision and gently
squeezed with forceps. The bile collected was then spread
on glass slides and examined immediately under polarizing
light microscopy for the presence of cholesterol crystals.
The bile ﬂow was determined as previously described
elsewhere.11 For tissues collection, the liver, gallbladder,
and small intestine excised from each mouse were rinsed
brieﬂy with cold phosphate-buffered saline, then aliquoted
and snap-frozen in liquid nitrogen.
Assays
Mice were sacriﬁced at 09:00. Liver tissues (weighing
w100 mg) were harvested and homogenized in chloro-
form/methanol (2:1 v/v) using a Polytron tissue grinder
(Glen Mills, Clifton, NJ). The extracts were dried under ni-
trogen ﬂow and resuspended in isopropanol. For the in vitro
model of cellular steatosis, mouse primary hepatocyte cells
were exposed to palmitate at a concentration of 0.5 mM.
Triglyceride concentrations were measured using commer-
cial kits (Sigma-Aldrich, St. Louis, MO; Biovision, Milpitas,
CA) as described elsewhere.11 Hepatic lipids were extracted
according to the Folch method and separated with silica gel
thin-layer chromatography plates as described previously
elsewhere.13,14
Western Blot Analysis
Western blot analysis was performed as previously
described elsewhere.15 The blots were incubated overnight at
4C with following primary antibodies: PKCb, total ERK1/2,
Figure 1. Relative ex-
pression of selective
protein kinase C (PKC)
isoforms in the livers of
male C57/BL6 WT mice
(n [ 6–8 mice per group)
fed either a chow or
lithogenic diet (MMLD)
for the indicated periods.
(A) Comparison of mRNA
expression levels for the
indicated PKC isoforms in
the livers of mice fed
MMLDL for 2 weeks. The
data are expressed relative
to corresponding level in
chow fed livers. Results are
expressed as mean ±
standard deviation. **P <
.01. (B) Protein levels of
indicated PKC isoforms
and b-actin were deter-
mined using immunoblot-
ting of pooled liver
extracts. Equal amounts of
protein were loaded per
well. (C) Polarizing light
microscopy examination of
cholesterol crystals in
pooled gallbladder bile
with the indicated geno-
type on feeding a litho-
genic diet for 1 or 2 weeks.
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(Sigma-Aldrich, St. Louis, MO); PKCa, PKCd, PKCε, phospho-
ERK1/2, phospho-Raf-1-Ser259, phospho-protein kinase B
(Akt)-Ser308, phospho-Akt-Ser473, phospho-glycogen synthase
kinase-a/b (pGSKa/b)-Ser21/9, phospho-c-Jun N-terminal ki-
nase (JNK)-Thr183/Tyr185, phospho-p38MAPK-Thr180/Tyr182,
and total Akt (Cell Signaling Biotechnology, Framington, MA);
and glycogen synthase (Abcam, MA). The band intensity was
quantiﬁed using a Bio-Rad GS-800 calibrated densitometer
with Quantify One analysis software (Bio-Rad Laboratories,
Hercules, CA).Cell Culture
The H2.35 cell line (purchased from the American Type
Culture Collection, Manassas, VA) was routinely grown in
Dulbecco’s modiﬁed Eagle’s medium with 1 g/L glucose,
200 nM dexamethasone, and 4% fetal bovine serum. To test
the effect of sterols on PKCb expression, the cells
were switched to medium containing 5% lipoprotein-
deﬁcient serum in the presence of sterols (2 mg/mL25-hydroxycholesterol plus 10 mg/mL cholesterol) or 30
mM lovastatin. After incubation for 16–20 hours, cell lysates
were probed by Western blotting for PKCb and b-actin.Isolation and Culture of Mouse Hepatocytes
Mouse hepatocytes were isolated from 12 week-old
C57BL/6J male mice from the Jackson Laboratory (Bar
Harbor, ME) as described previously for rat hepatocytes.16Infection of Primary Mouse Hepatocytes With
Adenovirus Overexpressing Green Fluorescent
Protein or Adenovirus Overexpressing Protein
Kinase C Isoform b
Primary mouse hepatocytes were seeded also at a den-
sity of 0.3  106 per well in a six-well plate with Dulbecco’s
modiﬁed Eagle’s medium containing 10% fetal bovine
serum and penicillin/streptomycin. The recombinant
adenovirus overexpressing green ﬂuorescent protein and
adenovirus overexpressing protein kinase C isoform b were
Table 1.Comparison of Gallstone Formation
Genotype
MMLD
(wk)
Total
mice
Mice with
stones
Incidence
(%)
WT, C57BL6 2 14 0 0
PKCb/,
C57BL6
2 13 5 38
WT, C57BL6 5 14 3 21
PKCb/,
C57BL6
5 13 13 100
WT, C57/
129Sv
2 14 0 0
PKCd/,
C57/129Sv
2 15 0 0
WT, C57/
129Sv
5 11 2 18
PKCb/,
C57/129Sv
5 15 3 20
MMLD, modiﬁed milk fat lithogenic diet; PKC, protein kinase
C; WT, wild type.
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where.17 After 36 hours of infection with 1 to 100 multi-
plicity of infection, cells were harvested with ice-cold
phosphate-buffered saline.
After spinning, the cell pellets were resuspended in cell
lysis buffer (20 mM Tris buffer, 2 mM ethyl-
enediaminetetraacetic acid [EDTA], 2mM [ethyl-
enebis(oxyethylenenitrilo)]tetraacetic acid [EGTA], 0.1%
sodium dodecyl sulfate, proteinase, and phosphatase in-
hibitors) for 30 minutes on ice, and sonicated brieﬂy. The
supernatant was collected after centrifugation. The protein
assay was performed before loading for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis.
Statistical Analysis
The results are shown as mean ± standard deviation (SD).
All statistical analysis was performed by Student’s t test or
analysis of variance (ANOVA) in Excel (Microsoft, Redmond,
WA). P < .05 was considered statistically signiﬁcant.
Results
Lithogenic Diet Speciﬁcally Induces Expression
of Hepatic Protein Kinase C b and d Isoforms
However Unlike PKCb, PKCd Deﬁciency Does
Not Promote Gallstone Formation
It is well established that the liver plays a critical role in
the regulation of cholesterol and bile acid homeostasis, and
is targeted by all three constituents of the lithogenic diet.
We initially assessed whether metabolic adaptation to the
lithogenic diet intake was associated with changes in he-
patic expression of PKCb and other PKC isoforms. Although
the mRNA level of PKCb and PKCd were quite low in the
liver of control mice, they were markedly increased after
lithogenic diet intake for 2 weeks. PKCa also showed a slight
increase, whereas expression of other PKC isoforms studied
remained unaffected (Figure 1A).
Likewise, PKCb and PKCd proteins levels showed strong
increases (>eightfold) after lithogenic diet exposure in a
time-dependent manner. A slight induction of the PKCb
isoform was observed at 1 to 3 days, and signiﬁcant in-
duction at week 1 with a peak at 2 weeks (the last time
point measured). The peak induction for PKCd was observed
at 1 week and remained elevated at week 2. A slight in-
duction of the PKCε protein was observed at day 1, reached
a peak at 1 week, and returned to normal by 2 weeks
(Figure 1B). In agreement with this study, both PKCb and
PKCd proteins showed greater abundance in the membrane-
fractions of lithogenic diet-fed livers (results not shown).
Because lithogenic diet increased levels of both PKCb
and PKCd, we hypothesized that, like PKCb deﬁciency, PKCd
deﬁciency might inﬂuence lithogenic diet-induced gallstone
formation. To determine the physiologic relevance of in-
duction in the development of gallstone formation, we
compared lithogenic diet-induced gallstone formation using
mice deﬁcient in individual isoform.
Interestingly, unlike PKCb deﬁciency, PKCd deﬁciency
did not inﬂuence lithogenic diet-induced gallstone forma-
tion (Table 1). Gallstones were found in 5/13 PKCb/ micecompared with 0/14 wild-type (WT) mice after 2 weeks of
lithogenic diet exposure. In contrast, no major difference
was observed between WT and PKCd/ mice even after
5 weeks of lithogenic diet feeding, whereas, as expected
from our previous study,11 all gallbladders from PKCb/
mice fed this diet were engorged with gallstones to varying
degrees. These results suggest that gallstone susceptibility
was speciﬁcally increased by the PKCb deﬁciency and not
affected at all by the PKCd deﬁciency.
We next compared hepatic PKCb induction relative to
the appearance of biliary cholesterol crystals. Establishing
the temporal relationship between these variables will not
only allow us to more accurately deﬁne the potential reg-
ulators of gallstone formation in a physiologic setting, but
more importantly will help to determine whether alteration
in PKCb expression is an early event in the development of
gallstone formation.
WT and PKCb/mice fed a lithogenic diet for 0, 1, and 2
weeks were analyzed for hepatic lipid contents, and also by
microscopic examination of the biliary cholesterol crystals.
As expected from our previous study,11 PKCb/ mice
showed an increased bile volume compared with WT mice
(results not shown). PKCb/ mice also demonstrated
markedly larger and more numerous aggregated cholesterol
monohydrate crystals in the gallbladder bile at 1 or 2 weeks
of lithogenic feeding (Figure 1C). Under higher magniﬁca-
tion, the crystals in PKCb/ mice after 2 weeks of litho-
genic diet appeared to be aggregated, solid cholesterol
monohydrate crystals.
Apolipoprotein E Deﬁciency Attenuates and Liver
X Receptor-a Deﬁciency Potentiates Lithogenic
Diet-Induced Hepatic Protein Kinase C Isoform
b Expression
Feeding a lithogenic diet to WT and PKCb/ mice
resulted in marked differences in hepatic triglyceride and
Figure 2. Potential rela-
tionship between diet-
induced hepatic protein
kinase C isoform b
(PKCb) and increased
hepatic cholesterol
levels. (A) Thin-layer chro-
matography of total lipid
extracts from livers of WT
and PKCb/ mice (n ¼ 2)
after a lithogenic diet
feeding for 0 or 2 weeks.
(B) Effect of feeding indi-
vidual components of a
lithogenic diet, diet con-
taining high fat and
cholesterol, or a lithogenic
diet containing all three
components for 2 weeks
on hepatic PKCb protein
levels (n ¼ 3). (C) Thin-layer
chromatography of total
lipid extracts from livers of
two of the mice fed an
indicated diet. The above
results are representative
of at least three separate
experiments. Each value
represents the mean ±
standard deviation. *P <
.05; **P < .01.
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exhibited signiﬁcantly lower hepatic triglyceride content,
but the hepatic total cholesterol content was signiﬁcantly
higher (Figure 2A).
To investigate the effect of individual components of the
lithogenic diet on hepatic PKCb induction, WT mice were fed
a chow or one of the three modiﬁed chows in which
cholesterol, cholate, or fat was in excess. As shown in
Figure 2B, unlike individual components alone, a diet con-
taining both high fat and cholesterol slightly increased the
hepatic PKCb expression, whereas maximal induction was
seen with the MMLD diet containing fat, cholesterol, and
cholic acid. The induction was also accompanied by an in-
crease in hepatic cholesterol content (see Figure 2C).
To determine further the role of hepatic cholesterol
uptake on the induction process, we examined lithogenicdiet-induced hepatic PKCb expression in ApoE/ mice.
Apolipoprotein E (ApoE) is a major apolipoprotein constit-
uent of chylomicron remnant particles and plays a critical
role in mediating the uptake of dietary cholesterol by the
liver. As a result, feeding a lithogenic diet to ApoE/ mice
was not expected to dramatically elevate the hepatic
cholesterol content, presumably as a result of the impaired
delivery of dietary cholesterol to the liver.18 As shown in
Figure 3A, lithogenic diet-induced hepatic PKCb expression
was greatly diminished in ApoE/mice compared with WT
controls, further supporting a possible role of dietary
cholesterol in the induction process.
Several earlier reports have highlighted the role of LXRs
in cholesterol efﬂux in animal cells.19,20 We next investi-
gated whether lithogenic diet feeding affected the hepatic
PKCb expression in mice lacking LXRa. As shown in
Figure 3. Effects of apolipoprotein E (ApoE) or liver X receptor-a (LXRa) deﬁciency on lithogenic diet-induced hepatic
protein kinase C isoform b (PKCb) expression. (A) ApoE/ deﬁciency attenuates diet-induced hepatic PKCb. Livers from
ApoE/ mice (n ¼ 2) fed a lithogenic diet for 2 weeks were examined for PKCb protein levels by immunoblotting. (B, C) LXRa
deﬁciency potentiates diet-induced hepatic PKCb expression; the induction is accompanied by an increase in hepatic
cholesterol content. Livers from wild-type and LXR/ mice (n ¼ 2 mice per diet group) fed modiﬁed milk fat lithogenic diet
(MMLD) for 2 weeks were used to examine hepatic PKCb protein levels and the lipid contents. (D) Effect of sterols (10 mg/mL
cholesterol plus 2 mg/mL 25-hydroxycholesterol, 24 hours) treatment on endogenous PKCb expression in mouse liver cell line
H2.35 cultured in medium supplemented with lipoprotein-deﬁcient serum. Equal amounts of cell extracts were probed for
PKCb expression by immunoblotting. This experiment was repeated twice with a similar outcome. *P < .05; **P < .001.
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PKCb expression in the livers of these mice compared with
those fed a chow diet. As expected, the LXRa/ mice fed a
lithogenic diet showed an excess accumulation of choles-
terol in the livers compared with WT mice (see Figure 3C).
The parallels between the increase in hepatic cholesterol
content and PKCb induction prompted us to analyze the
effects of sterols on endogenous PKCb expression in
cultured liver cell line. Sterols treatment alone for 24 hours
slightly increased PKCb expression (see Figure 3D), lendingfurther support to the idea that an increase in hepatic
cholesterol content may contribute, at least in part, to the
induction process.Lithogenic Diet-Fed PKCb/Mice Show Greater
Hepatic Insulin Sensitivity Than Wild-Type Mice
Hepatic insulin resistance was recently shown to play a
part in gallstone formation through regulation of bile acid
synthesis.21 We therefore investigated phosphorylation
July 2015 PKCb Negatively Regulates Raf-1 Signaling Cascade 401status of Akt/PKB and downstream GSKs as markers of in-
sulin sensitivity in the livers of lithogenic diet-fed mice.
Phosphorylation levels of both Akt-Ser308 (wﬁvefold) and
GSKs (wfourfold) in vivo were higher in PKCb/ mice
compared with WT mice (Figure 4), suggesting that PKCb/
deﬁciency increases hepatic insulin signaling even in mice
fed a lithogenic diet. In view of previous demonstration that
physiologic concentrations of insulin stimulate CYP7A1
mRNA expression,22 it is evident that alterations in insulin
signaling may not account for greater suppression of Cyp7a1
in PKCb/ livers.Figure 5. Effects of lithogenic diet feeding on ileum
ﬁbroblast growth factor 15 (FGF15) and protein kinase C
isoform b (PKCb) expression levels. (A) PKCb deﬁciency
signiﬁcantly induces ileum FGF15 expression in response to
lithogenic diet intake. FGF15 mRNA expression levels were
analyzed in the ileum of WT and PKCb/ mice fed a chow or
lithogenic diet for 2 weeks. (B) The ilea from the animals were
also used to examine PKCb expression levels by immuno-
blotting. Levels of FGF15 and PKCb in WT mice fed a chow
diet were assigned a value of 1. Results are expressed as the
mean ± standard deviation. *P < .05, **P < .01 (n ¼ 5).Protein Kinase C Isoform b Deﬁciency Stimulates
Ileum Fibroblast Growth Factor 15 Expression
and Activity
Because the expression levels of genes implicated in bile
acid, cholesterol or phospholipids transporters were not
signiﬁcantly altered in the livers of lithogenic-fed PKCb/
mice,11 we speculated that changes in hepatic Cyp7a1
expression either were secondary to alterations in the bile
acid pool size and composition or were caused by pertur-
bation of signaling factor secreted from the intestine. Ileal
FGF15 is the primary mediator of bile acid feedback inhi-
bition of hepatic Cyp7a1 in vivo, so we examined the
expression levels of ileum FGF15 between genotypes.
Figure 5A shows that mice fed a lithogenic diet for 2 weeks
demonstrated signiﬁcant up-regulation of ileal FGF15 mRNA
expression in PKCb/ mice compared with WT mice, sug-
gesting that Cyp7a1 suppression may be related, at least in
part, to enhanced ileal FGF15 expression by PKCb deﬁ-
ciency. We also examined the effect of feeding a lithogenic
diet on intestinal PKCb expression and observed a slight
elevation in PKCb expression (Figure 5B).
Recent studies have also established that ERK1/2 acti-
vation is associated with suppression of hepatic Cyp7a1
gene expression by FGF15.23,24 Activation of ERK1/2 is
catalyzed by the dual speciﬁcity kinase MEK1/2. To
phosphorylate and activate ERK1/2, MEK1/2 must ﬁrst it-
self be serine-phosphorylated by Raf-1. We thereforeFigure 4. Lithogenic diet-fed PKCbL/L mice exhibit
greater liver insulin-sensitivity than control mice. Wild-
type (WT) and PKCb/ mice (n ¼ 2) fed a lithogenic diet
for 0 or 2 weeks were either untreated or injected with insulin
(0.9 U/kg body weight), and the livers were analyzed for the
insulin-signaling proteins. Western blots are representative of
two separate experiments. Fold change shows the band in-
tensity ratio of PKCb/ over WT. *P < .05, n ¼ 4.analyzed Raf-1 and MEK1/2 activations using the indicated
phospho-speciﬁc antibodies. The results presented in
Figure 6A shows an increase in inhibitory serine 259
phosphorylation for Raf-1 in the lithogenic diet-fed livers of
WT mice. As expected, it was accompanied by a decrease in
MEK1/2 and ERK1/2 activation, suggesting that PKCb uses
Raf-1 inhibition as the main interface for the negative
regulation of downstream MEK and ERK1/2 phosphoryla-
tion. We also compared phospho-ERK1/2 levels in the livers
of lithogenic diet-fed WT and PKCb/ mice. The PKCb/
livers showed increased ERK1/2 activation compared with
WT (see Figure 6B), an observation consistent with our
earlier report on feeding mice a lithogenic diet containing
cocoa butter.11
Interestingly, in contrast to ERK1/2, the lithogenic diet
induced p38MAPK in a PKCb-independent manner (see
Figure 6A and B). As expected, overexpression of PKCb
protein in mouse primary hepatocytes also reduced ERK1/2
phosphorylation (see Figure 6C), suggesting that the nega-
tive inﬂuence of PKCb on ERK1/2 signaling is also operative
in the intact hepatocytes. Because ERK1/2 and various PKC
isoforms have been implicated in regulating the expression
and function of genes involved in various aspects of
cholesterol and bile acid homeostasis, we also investigated
the expression of these genes. As shown in Figure 6D,
expression of both Cyp7a1 and Cyp8b1 genes were
dramatically reduced, whereas expression of LDL receptor
and sterol response element-binding protein 2 (SREBP-2)
genes were signiﬁcantly up-regulated.
Discussion
The lithogenic diet containing cholesterol, cholic acid,
and fat has been used extensively to induce and study the
pathology and genetics of gallstone formation in inbred
mice.25 Using a well-established mouse model for
Figure 6. Protein kinase C isoform b (PKCb) negatively regulates hepatic proto-oncogene serine/threonine-protein
kinase Raf-1/mitogen-activated protein (MAP) kinase kinase/extracellular signal regulated kinase-1/2 (Raf-1/MEK/
ERK1/2) signaling cascade in the liver. (A) Comparison of expression and phosphorylation levels of MAPKs in the pooled
liver extracts of mice (n ¼ 5) fed a lithogenic diet for the indicated periods. (B) Comparison of phosphorylation levels of ERK1/2
and p38MAPK in the pooled liver extracts of wild-type (WT) and PKCb/ mice (n ¼ 5) fed a lithogenic diet for 2 weeks. (C)
Overexpression of PKCb reduces basal and FGF15-induced ERK1/2 phosphorylation in mouse hepatocytes. Primary mouse
adipocytes were infected with either adenovirus overexpressing green ﬂuorescent protein or adenovirus overexpressing
protein kinase C isoform b at an multiplicity of infection of 0 and 100; after 24 hours the PKCb and phospho-ERKs levels were
measured by immunoblotting using anti-phospho-ERK1/2. The above Western blots are representative of two separate
experiments. (D) Comparison of hepatic gene expression between lithogenic diet-fed WT and PKCb/ mice. Levels for
each gene in WT mice were assigned a value of 1. Each value represents the mean ± standard deviation (n ¼ 5 mice/group).
*P < .05; **P < .01.
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feeding speciﬁcally induces the expression of both PKCb and
PKCd isoforms in the liver, and that PKCb induction atten-
uates gallstone formation. PKCb induction was dependent
on the presence of all three components of the lithogenic
diet, whereas slight or no increase in PKCb expression was
observed by feeding diets in which cholesterol, cholate, or
fat was in excess. The fact that all three components were
required to induce gallstone formation in mice suggests that
the lithogenic diet induced distinct intracellular signaling
pathway(s) when compared with the individual components
of the lithogenic diet. These results, combined with our
earlier results showing that PKCb deﬁciency stimulates diet-
induced gallstone formation,11 provide direct evidence that
PKCb induction represents an adaptive mechanism and
plays a protective role in the metabolic adaptation to a
lithogenic diet.
The mechanism of nutritional regulation of PKCb
expression/activation with a lithogenic diet remains un-
known and requires further investigation. The induction of
PKCb could involve nuclear receptors and transcriptionfactors targeted by the components of this diet, bile acid
stimulation of diacylglycerol synthesis,26 or activation of
phospholipase C and increased calcium mobilization,27
resulting in the transcriptional induction of PKCb expres-
sion. A recent report that DNA methylation regulates PKCb
expression28 suggests that a lithogenic diet could also in-
ﬂuence DNA methylation at the PKCb promoter level.
The interaction between genes and the environment is
an integral component of evolution, and includes cross-talk
between a subset of genes and the diet, which results in
adaptations to speciﬁc nutrients. It is well-established that
dietary components can inﬂuence the expression of genes
controlling metabolic processes via signal transduction
pathways affecting transcriptional signal cascades and net-
works. Given the role of PKCb in gallstone formation, it is
evident that PKCb may mediate the effects of a lithogenic
diet via a variety of downstream signal-transducing path-
ways critical for bile lithogenicity and the subsequent
development of gallstones. It is apparent that pathways
involving PKCb-dependent modiﬁcations of nuclear factors
are unlikely targets to modify cytochrome P450 enzymes
Figure 7. Proposed model for the mechanism by which
protein kinase C isoform b (PKCb) activation in the liver
and ileum contributes to adaptive response for proper
handling of a large supply of dietary fat, cholesterol, and
bile acids to prevent hepatic overaccumulation of toxic
cholesterol. Cholesterol homeostasis is achieved through
regulation of cholesterol uptake, cholesterol biosynthesis,
cholesterol conversion to bile acids, and excretion of bile
acids. The data presented in this study are consistent with a
two-pronged mechanism by which PKCb deﬁciency con-
tributes to dysfunctional cholesterol homeostasis through
disturbing the ﬁbroblast growth factor 15/extracellular signal
regulated kinase (FGF15/ERK) and Raf-1 hepatic proto-
oncogene serine/threonine-protein kinase/mitogen-activated
protein (MAP) kinase kinase/extracellular signal regulated
kinase-1/2 (Raf-1/MEK/ERK1/2) regulatory axes.
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to suppress and activate transactivation, respectively.
In the present study, we therefore explored other
signaling pathways downstream of PKCb that suppressed
the expression of cytochrome P450 isoforms in response to
lithogenic diet exposure. Ileal FGF15 is the primary medi-
ator of bile acid feedback inhibition of hepatic cytochrome
P450 isoforms.3,29 Our results suggest that PKCb is a
repressor of ileum FGF15 expression. We found that litho-
genic diet-fed mice demonstrated the up-regulation of ileal
FGF15 expression. However, the degree of up-regulation
was greater in PKCb/ mice compared with WT mice,
suggesting that cytochrome P450 isoform suppression may
be related, at least in part, to enhanced ileal FGF15
expression induced by PKCb deﬁciency. The potential
mechanism of FGF15 induction may involve alterations in
the vitamin D receptor, FXR, and/or RXRa activity, which
are required for FGF15 expression.30 Phosphorylation of the
vitamin D receptor speciﬁcally by PKCb has been shown to
suppress its function and thereby can modulate recruit-
ment, function, and/or afﬁnity of coactivator complex.9 PKC
activation is also known to control nuclear localization of
nuclear receptors and their stability.7,10,31Our results suggest that PKCb is a critical link in an
adaptive response for proper handling of high dietary fat
and cholesterol by modulating hepatic ERK1/2 activity to
coordinately regulate the cellular cholesterol biosynthesis,
uptake, and degradation. Our data are consistent with a two-
pronged mechanism by which intestinal and liver PKCb
deﬁciency converges on liver ERK1/2 to modify the
expression of genes involved in the cholesterol and bile acid
homeostasis (Figure 7). One pathway may cause the stim-
ulation of intestinal FGF15 expression, leading to an in-
crease in ERK1/2 activity in the liver via FGFR4 and FGFR4
coreceptor b-Klotho, resulting in the suppression of Cyp7a1
and Cyp8b1 gene transcription and the reduction of
cholesterol catabolism. The other pathway may rely on the
negative regulation of the Raf-1/MEK/ERK signaling axis by
PKCb itself in the liver, resulting in further activation of
ERK1/2 to reduce cholesterol catabolism in PKCb/ mice.
Both mechanisms may cooperate to maximize the effec-
tiveness of PKCb deﬁciency on hepatic ERK1/2 activation.
It is interesting to note from our previous work that
ERK1/2 played an important role in controlling hepatic LDL
receptor expression.32,33 PKCb deﬁciency is therefore
predicted to induce hepatic LDL receptor expression to
further promote cholesterol accumulation. In addition,
ERK1/2 was reported to regulate the activity of SREBP-2
and consequently its expression due to self-regulation.34,35
In agreement with this model, lithogenic diet-fed PKCb
deﬁcient livers showed an increase in the expression of
hepatic LDL receptors and SREBP-2 (Figure 6). Additionally,
in agreement with the protective role of PKCb activation,
the modulation of either PKCa or ERK1/2 has been shown
to inﬂuence cholesterol efﬂux.36,37 Finally, inhibition of
ERK1/2 also has been shown to promote very-low-density
lipoprotein assembly in HepG2 cells,38 and as a result,
PKCb deﬁciency should inhibit very-low-density lipoprotein
assembly. The net effect of PKCb deﬁciency would be to
promote hepatic cholesterol accumulation as was observed
for PKCb/ mice. This model has the potential to explain
how PKCb directly or indirectly through ERK1/2 caused the
differential expression of genes involved in the cholesterol
uptake, biosynthesis, and catabolic reduction of the hepatic
cholesterol burden. Establishing PKCb as the prime kinase
involved in ﬁne-tuning the hepatic ERK1/2 activation in
response to lithogenic diet feeding introduces a new model
system that can be used to investigate the FGF15 regulatory
mechanisms within a functional context. Negative in vivo
regulation of the hepatic Raf/MEK/ERK cascade by PKCb is
unexpected due to numerous in vitro studies in cell culture
models, suggesting that PKCb is required for ERK1/2
activation.39,40
The additional means by which ERK1/2 activation is
positively inﬂuenced by PKCb deﬁciency may be attribut-
able to the differences in hepatic insulin sensitivity. Over-
expression of PKCb in the liver, similar to its overexpression
in muscle, may result in hepatic insulin resistance,41 a
condition known to affect ERK1/2 activation and the
expression of both Cyp7a1 and Cyp8b1 genes. Insulin has
been known to initiate signaling cascades through Akt and
ERK1/2 signaling pathways and has been shown to act
404 Huang and Mehta Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 4synergistically with FGF15 to activate these critical signaling
pathways.42,43 Considering the physiologically important
roles of Cyp7a1 in regulating the pool size and of Cyp8b1 in
controlling bile acid proﬁles, it is possible that these genes
may have acquired more sophisticated expression control
mechanisms to allow for a greater ﬂexibility in the precise
regulation of bile acid homeostasis in response to alter-
ations in nutrition and growth conditions. Furthermore,
extremely high PKCb levels in the livers of lithogenic diet-
fed animals could help to control insulin and FGF15
signaling pathways. Further studies are needed to deter-
mine how insulin- and FGF15-speciﬁc phosphorylation of
ERK1/2 is coordinated with PKCb-dependent signaling
events to respond appropriately to environmental
conditions.
In conclusion, we have demonstrated that PKCb activa-
tion and signaling represent a critical link between litho-
genic diet intake and an adaptive response for proper
handling of high dietary fat, cholesterol, and bile acid by the
modulation of the hepatic ERK1/2 activity. PKCb may pro-
vide a novel therapeutic target for metabolic disease treat-
ment in the future.
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